Details For Selected Brain Tumor Treatment

Sponsored By

Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma (ACT IV)

Please Click On The Above Banner For More Details

Last updated refers to the date when our listing for each treatment was last updated.
ID is our internal ID - starting with VT.
Min Karnofsky is a general guide to how well you have to function to use this treatment
For trials that also have a NCT number, you can click that number to pop up the listing from the clinicaltrials.gov website.

Back to New Treatments List



		Treatment Name:		Cilengitide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

		Keywords:		Cilengitide

		Phase:		Phase 1/2

		Treatment ID#s:		VT1168 NCT00085254

		Age Group:		Adults Only

		Min Karnofsky Score:		60: Requires occasional assistance but is able to care for most of own needs

		Conditions:		Newly Diagnosed: Y Recurrent: N Prior Surgery is Allowed Prior Radiation is Not Allowed Prior Chemotherapy is Not Allowed RATIONALE: Cilengitide may stop the growth of cancer by stopping blood flow to the tumor. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining cilengitide with radiation therapy may kill more tumor cells. PURPOSE: Randomized phase I/II trial to study the effectiveness of combining cilengitide with radiation therapy in treating patients who have newly diagnosedglioblastoma multiforme.

		Last Updated:		05/01/2007

		Tumor Types:		Glioblastoma Multiforme Gliosarcoma


		Comments:

		Treatment Type:		Chemotherapy Radiation.

		Contact:		University of Alabama at Birmingham Comprehensive Cancer Center Burt Nabors, MD Assistant Professor 1813 Sixth Ave South RAC M030 Birmingham, AL 35294 Phone:205 934-1432 Fax: 205 975-7546 Click here to send an email Website: www.braintumor.uab.edu Mass. General Hospital - Brain Tumor Center Tracy Batchelor, MD, MPH Executive Director Brain Tumor Center Suite 315, Cox Building Boston, MA 02114 Phone:617-724-8770 Fax: (617)724-8769 Click here to send an email Website: brain.mgh.harvard.edu Johns Hopkins Hospital Larry Kleinberg, MD Contact: Terrence Caldwell 600 N. Wolfe St., Room I-170 Baltimore, MD 21287 Phone:443-287-1889 Fax: ( ) - Click here to send an email Website: www.nabtt.org/johns.html Henry Ford Hospital Tom MikKelsen, MD, FRCP(C) Co-Director Contact: Dr. Tom Mikelsen Hermelin Brain Tumor Center E&R3096 Henry Ford Hospital 2799 West Grand Blvd Detroit, MI 48202- Phone:313 916-8641 Fax: 313 916-9855 Click here to send an email Website: www.henryfordhealth.org/body.cfm?id=38441&action=detail&ref=968 Wake Forest Comprehensive Cancer Center Glenn J. Lesser, MD Contact: Jennifer MacLean Winston-Salem, NC 27157 Phone:336-716-3539 Click here to send an email Cleveland Clinic Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center Gene Barnett, MD : Professor and Director, Rose Ella Burkhardt Brain Tumor & Neuro-Oncology Center Cleveland, OH 44195 Phone:216-445-1379 Fax: 216-444-0924 Click here to send an email Website: my.clevelandclinic.org/brain_tumor/default.aspx Hospital of the Univ. of PA Steven Brem, MD 3 Silverstein 3400 Spruce Street Philadelphia, PA 19104 Phone:1-800-789-PENN (7366) Email not available Website: www.pennmedicine.org/wagform/MainPage.aspx?config=provider&P=PP&ID=13149 U. Of Pennsylvania Myrna Rosenfeld, MD Department of Neurology Philadelphia, PA 19104 Phone:215-746-2820 Email not available